Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390

NCT00996216 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Eltrombopag
DRUG: Antiviral therapy

Sponsor

GlaxoSmithKline